BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 19752333)

  • 1. Cost-Utility of Early Breast Cancer Surveillance in Survivors of Thoracic Radiation-Treated Adolescent Hodgkin Lymphoma.
    Furzer J; Tessier L; Hodgson D; Cotton C; Nathan PC; Gupta S; Pechlivanoglou P
    J Natl Cancer Inst; 2020 Jan; 112(1):63-70. PubMed ID: 31070751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and Cost-Effectiveness of Survivorship Care for Survivors of Hodgkin Lymphoma (INSIGHT Study): Protocol for a Multicenter Retrospective Cohort Study With a Quasi-Experimental Design.
    Lammers EMJ; Zijlstra JM; Retèl VP; Aleman BMP; van Leeuwen FE; Nijdam A;
    JMIR Res Protoc; 2024 Apr; 13():e55601. PubMed ID: 38635308
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-Effectiveness Analysis of Follow-Up Schedule for Hepatocellular Carcinoma after Radiofrequency Ablation.
    Hu S; Wu X; Wei M; Ling Y; Zhu M; Wang Y; Chen Y; Jin M; Peng Z
    J Oncol; 2022; 2022():3569644. PubMed ID: 35345515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High risk of cardiovascular side effects after treatment of Hodgkin's lymphoma - is there a need for intervention in long-term survivors?
    Andersson A; Enblad G; Erlanson M; Johansson AS; Molin D; Tavelin B; Näslund U; Melin B
    Ups J Med Sci; 2021; 126():. PubMed ID: 33889307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Traditional Cardiovascular Risk Factors and Individual Prediction of Cardiovascular Events in Childhood Cancer Survivors.
    Chen Y; Chow EJ; Oeffinger KC; Border WL; Leisenring WM; Meacham LR; Mulrooney DA; Sklar CA; Stovall M; Robison LL; Armstrong GT; Yasui Y
    J Natl Cancer Inst; 2020 Mar; 112(3):256-265. PubMed ID: 31161223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paediatrics: Addressing the health burden of childhood cancer survivors - improvements are needed.
    Henderson TO; Oeffinger KC
    Nat Rev Clin Oncol; 2018 Mar; 15(3):137-138. PubMed ID: 29384148
    [No Abstract]   [Full Text] [Related]  

  • 7. Cardiovascular effects of Hodgkin's lymphoma: a review of literature.
    Jacob A; Thyagarajan B; Kumar MP; Shaikh N; Sharon D
    J Cancer Res Clin Oncol; 2018 Jan; 144(1):99-107. PubMed ID: 29255934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel concepts in radiation-induced cardiovascular disease.
    Cuomo JR; Sharma GK; Conger PD; Weintraub NL
    World J Cardiol; 2016 Sep; 8(9):504-519. PubMed ID: 27721934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Pound of Cure Requires An Ounce (or More) of Prevention: Survivorship and Complications of Therapy for Hematologic Malignancies.
    Luskin MR; Banerjee R; Del Percio S; Loren AW
    Curr Hematol Malig Rep; 2015 Sep; 10(3):225-36. PubMed ID: 26162948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular disease in survivors of hematopoietic cell transplantation.
    Armenian SH; Chow EJ
    Cancer; 2014 Feb; 120(4):469-79. PubMed ID: 24166350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Appropriate surveillance for late complications in patients in remission from Hodgkin lymphoma.
    Darrington DL; Vose JM
    Curr Hematol Malig Rep; 2012 Sep; 7(3):200-7. PubMed ID: 22743837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Navigator channel adaptation to reconstruct three dimensional heart volumes from two dimensional radiotherapy planning data.
    Ng A; Nguyen TN; Moseley JL; Hodgson DC; Sharpe MB; Brock KK
    BMC Med Phys; 2012 Jan; 12():1. PubMed ID: 22257738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Care of the adult Hodgkin lymphoma survivor.
    Thompson CA; Mauck K; Havyer R; Bhagra A; Kalsi H; Hayes SN
    Am J Med; 2011 Dec; 124(12):1106-12. PubMed ID: 22114824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost effectiveness and screening interval of lipid screening in Hodgkin's lymphoma survivors.
    Chen AB; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2009 Nov; 27(32):5383-9. PubMed ID: 19752333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computed tomography screening for lung cancer in Hodgkin's lymphoma survivors: decision analysis and cost-effectiveness analysis.
    Das P; Ng AK; Earle CC; Mauch PM; Kuntz KM
    Ann Oncol; 2006 May; 17(5):785-93. PubMed ID: 16500905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis.
    Wattson DA; Hunink MG; DiPiro PJ; Das P; Hodgson DC; Mauch PM; Ng AK
    Int J Radiat Oncol Biol Phys; 2014 Oct; 90(2):344-53. PubMed ID: 25104066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness analysis of computerized tomography in the routine follow-up of patients after primary treatment for Hodgkin's disease.
    Guadagnolo BA; Punglia RS; Kuntz KM; Mauch PM; Ng AK
    J Clin Oncol; 2006 Sep; 24(25):4116-22. PubMed ID: 16943528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of cardiac resynchronisation (biventricular pacing) for heart failure: systematic review and economic model.
    Fox M; Mealing S; Anderson R; Dean J; Stein K; Price A; Taylor RS
    Health Technol Assess; 2007 Nov; 11(47):iii-iv, ix-248. PubMed ID: 17999842
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.